文献速递产科母胎医学

妊娠期糖尿病与血糖监测频率:一项随机对照试验

Gestational Diabetes Mellitus and Frequency of Blood Glucose Monitoring: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2017-01-01

这项在五个中心开展的非劣效性随机对照试验纳入293例妊娠期糖尿病患者,比较隔日四次与每日四次血糖监测。隔日组平均出生体重差异为-41 g(90% CI -137至54 g),置信区间上限小于165 g,达到非劣效性,且隔日组监测依从性更高(92% vs 89%,P<.01)。

要点

  • 在血糖控制良好的妊娠期糖尿病患者中,隔日四次血糖监测的出生体重不高于每日四次监测。
  • 隔日监测组出生体重平均差异为-41 g(90% CI -137至54 g),非劣效性成立。
  • 隔日监测组血糖监测依从性高于每日监测组(92% vs 89%,P<.01)。

核心结论

  • 在血糖控制良好的妊娠期糖尿病患者中,隔日检测血糖与每日检测相比未增加出生体重,且提高了监测依从性。

研究设计与样本

  • 非劣效性随机对照试验,在五个中心开展,从2013年5月至2016年5月共随机分配293例妊娠期糖尿病患者,其中149例(51%)每日四次监测血糖,144例(49%)隔日四次监测血糖。

主要发现

  • 两组在需要医疗处理、引产、分娩孕周、分娩方式、子痫前期发生率或肩难产方面无显著差异。
  • 出生体重两组相似,平均差异为-41 g(90% CI -137至54 g),90%置信区间上限小于165 g,确立非劣效性。
  • 隔日监测组血糖监测依从性高于每日监测组(92% vs 89%,P<.01)。
  • 巨大儿和出生体重大于第95百分位的发生率差异无临床意义,新生儿结局包括新生儿低血糖两组相似。

关键数值与推荐

  • 非劣效性界值为平均出生体重不高于165 g(假设平均出生体重3,296 g,5%差异)。
  • 总样本量286例允许以单侧0.05显著性水平检验非劣效性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether testing blood glucose four times daily compared with four times every other day would lead to similar birth weights among patients with gestational diabetes mellitus (GDM). METHODS: This noninferiority randomized controlled trial was conducted at five centers. After receiving a diagnosis of GDM, women tested their blood glucose every day for 7 days. After that period, compliant women without hyperglycemia requiring treatment were randomized to either blood glucose testing four times a day or every other day. Noninferiority would be declared if the mean birth weight in the every-other-day group was no higher than 165 g (5% difference assuming an average birth weight of 3,296 g) compared with the four times a day group. A total sample size of 286 women allowed noninferiority to be tested (one-sided .05 level of significance). RESULTS: From May 2013 to May 2016, of the 293 women with GDM who were randomized, 149 (51%) were tested four times a day and 144 (49%) were tested every other day. Between the two groups, there were no significant differences with regard to need for medical treatment, induction, gestational age at delivery, mode of delivery, rate of preeclampsia, or shoulder dystocia. Birth weight was similar between both groups and the upper bound of the 90% confidence interval (CI) was less than 165 g, establishing noninferiority with a mean difference of -41 g (90% CI -137 to 54 g). Rate of compliance with blood glucose testing was higher in the every-other-day group (89% compared with 92%, P<.01). The differences in rates of macrosomia and birth weight greater than the 95th percentile were not clinically significant. Neonatal outcomes including neonatal hypoglycemia were similar. CONCLUSION: Among patients with well-controlled GDM, testing blood glucose values every other day did not increase birth weight, although it did increase compliance with testing when compared with women who tested every day. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT01818557.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mendez-Figueroa H, Schuster M, Maggio L, et al. Gestational Diabetes Mellitus and Frequency of Blood Glucose Monitoring: A Randomized Controlled Trial. Obstet Gynecol. 2017. PMID: 28594772. doi:10.1097/AOG.0000000000002101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。